Mochida Pharmaceutical Co., Ltd. (TYO:4534)

Mochida Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	25,582	28,064	45,154	33,290	47,010	48,415
Short-Term Investments	2,990	2,993	5,996	13,499	13,499	13,499
Cash & Short-Term Investments	28,572	31,057	51,150	46,789	60,509	61,914
Cash Growth	-45.80%	-39.28%	9.32%	-22.67%	-2.27%	-2.48%
Receivables	38,807	36,478	31,617	34,838	27,806	31,676
Inventory	37,837	36,121	33,295	30,278	24,404	23,127
Other Current Assets	5,202	15,365	3,607	4,757	4,660	4,731
Total Current Assets	110,418	119,021	119,669	116,662	117,379	121,448
Property, Plant & Equipment	16,758	16,302	15,940	15,874	15,049	14,528
Long-Term Investments	55,296	45,455	21,740	23,169	21,722	22,758
Other Intangible Assets	1,045	1,121	920	721	797	713
Long-Term Deferred Tax Assets	1,393	820	1,851	2,372	3,883	3,691
Other Long-Term Assets	1	1	1	2	1	1
Total Assets	184,911	182,720	160,121	158,800	158,831	163,139

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	12,917	10,777	8,660	12,182	9,957	11,899
Accrued Expenses	2,181	2,452	2,357	2,178	2,374	2,711
Current Income Taxes Payable	2,602	2,970	1,510	593	501	1,652
Other Current Liabilities	10,737	11,535	12,375	11,120	14,426	13,594
Total Current Liabilities	28,437	27,734	24,902	26,073	27,258	29,856
Long-Term Debt	10,000	10,000	-	-	-	-
Pension & Post-Retirement Benefits	3,321	3,337	3,690	3,908	4,133	4,270
Long-Term Deferred Tax Liabilities	-	493	-	-	-	-
Other Long-Term Liabilities	801	831	835	853	666	367
Total Liabilities	42,559	42,395	29,427	30,834	32,057	34,493

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	7,229	7,229	7,229	7,229	7,229	7,229
Additional Paid-In Capital	1,871	1,871	1,871	1,871	1,871	1,871
Retained Earnings	126,540	121,251	116,114	117,022	118,943	121,668
Treasury Stock	-4,325	-3,270	-3,267	-7,021	-7,114	-9,617
Comprehensive Income & Other	11,037	13,244	8,747	8,865	5,845	7,495
Shareholders' Equity	142,352	140,325	130,694	127,966	126,774	128,646
Total Liabilities & Equity	184,911	182,720	160,121	158,800	158,831	163,139

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	10,000	10,000	-	-	-	-
Net Cash (Debt)	18,572	21,057	51,150	46,789	60,509	61,914
Net Cash Growth	-64.77%	-58.83%	9.32%	-22.67%	-2.27%	-2.48%
Net Cash Per Share	525.00	593.99	1442.84	1304.66	1628.34	1624.95
Filing Date Shares Outstanding	35.12	35.42	35.45	35.45	36.53	37.57
Total Common Shares Outstanding	35.12	35.45	35.45	35.45	36.53	37.57
Working Capital	81,981	91,287	94,767	90,589	90,121	91,592
Book Value Per Share	4052.89	3958.43	3686.66	3609.61	3470.15	3424.20
Tangible Book Value	141,307	139,204	129,774	127,245	125,977	127,933
Tangible Book Value Per Share	4023.13	3926.81	3660.71	3589.27	3448.33	3405.23

Data Source: S&P Global Market Intelligence Last updated: Nov 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 15, 2026

Data Sources Report a data error